| Overview |
| bsm-62975r-100ul |
| EDG3 Recombinant Antibody |
| WB, IHC-P, IHC-F, IF(IHC-P), IF(ICC) |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human EDG3 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 1903 |
| Q99500 |
| Cell membrane |
| EDG3; LPB3; S1P receptor 3; S1P3; S1pr3. |
| Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis. |
| Application Dilution |
| WB |
1:1000-2000 |
| IHC-P |
IHC-P1:100-200 |
| IHC-F |
IHC-F1:100-200 |
| IF(IHC-P) |
IFIHC-P1:100-200 |
| IF(ICC) |
IFICC1:50-200 |